Natural Anthraquinones as Promising MAPK3 Inhibitors for Complementary Cancer Therapy
Objective. MAPK3 activates several nuclear transcription factors, including c-Jun and c-fos, by phosphorylating its downstream cytoplasmic protein, thereby contributing to cell proliferation and survival. Different carcinomas’ initiation, progression, cancer cell metastasis, and drug resistance have...
Main Authors: | Samaneh Vaziri-Amjad, Massoud Moradi-Najmi, Amir Taherkhani |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2023/6683470 |
Similar Items
-
Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
by: Amir Taherkhani, et al.
Published: (2023-01-01) -
Damnacanthal: a promising compound as a medicinal anthraquinone
by: Abu, Nadiah, et al.
Published: (2014) -
Herbal Metabolites as Potential Carbonic Anhydrase Inhibitors: Promising Compounds for Cancer and Metabolic Disorders
by: Ebrahim Yarmohammadi, et al.
Published: (2023-09-01) -
Anthraquinones as Inhibitors of SOS RAS-GEF Activity
by: Alberto Fernández-Medarde, et al.
Published: (2021-07-01) -
Anthraquinone-Quinizarin Copolymer as a Promising Electrode Material for High-Performance Lithium and Potassium Batteries
by: Elena V. Shchurik, et al.
Published: (2023-07-01)